Mirapro® 15 mg is an antidepressant medication containing Mirtazapine, manufactured by Square Pharmaceuticals Ltd. It is primarily prescribed for the treatment of Major Depressive Disorder (MDD). Mirtazapine functions by enhancing central noradrenergic and serotonergic activity through antagonism of central presynaptic α2-adrenergic inhibitory autoreceptors and heteroreceptors, leading to increased levels of norepinephrine and serotonin in the brain. This mechanism helps alleviate symptoms of depression, such as mood disturbances, sleep issues, and appetite changes